| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 11,679 | 9,191 | 14,862 | 19,282 | | Cost of Revenue | 11,617 | 9,187 | 13,402 | 19,809 | | | Gross Profit | 62 | 4 | 1,460 | (526) | | | Operating Expenses | | Research Development | 2,188 | 2,244 | 1,871 | (3,386) | | Selling General and Administrative | 4,885 | 4,668 | 4,676 | 4,802 | | Non Recurring | 211 |
-
|
-
| 279 | | Others | 79 | 79 | 79 | 79 | | | | Total Operating Expenses | 7,362 |
-
|
-
| 1,773 | | | | Operating Income or Loss | (7,300) | (6,986) | (5,166) | (2,300) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 82 | 1,291 | (5,506) | 1,752 | | Earnings Before Interest And Taxes | (7,218) | (5,695) | (10,672) | (548) | | Interest Expense | 39 | 138 | 82 | 88 | | Income Before Tax | (7,257) | (5,833) | (10,754) | (636) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,257) | (5,833) | (10,754) | (636) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 769 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,257) | (5,833) | (10,754) | 134 | | Preferred Stock And Other Adjustments | (1,281) | (1,275) | (1,143) | (1,111) | | | Net Income Applicable To Common Shares | ($8,539) | ($7,108) | ($11,897) | ($977) |
|
0.11% Nasdaq 0.00%
Income Statement
